Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marcus Schmidt

Showing results (241-250 of 344) with videos related to

Pageof 35
Sort By:
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|December 5, 2013
Synchronous ovarian and endometrial cancer--an international multicenter case-control studyFlorian Heitz, Frederic Amant, Christina Fotopoulou, et al.
European Journal of Cancer (Oxford, England : 1990)|October 5, 2023
Adjuvant capecitabine versus nihil in older patients with node-positive/high-risk node-negative early breast cancer receiving ibandronate - The ICE randomized clinical trialMarcus Schmidt, Ulrike Nitz, Toralf Reimer, et al.
Heliyon|August 22, 2024
Changes in modifiable risk factors in women at increased risk for breast and ovarian cancer during the COVID-19 pandemicKathrin Stewen, Annika Droste, Christian Ruckes, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|October 9, 2012
Mitotic figure counts are significantly overestimated in resection specimens of invasive breast carcinomasHans-Anton Lehr, Candice Rochat, Cornelia Schaper, et al.
Inorganic Chemistry|July 19, 2017
Intermediate-Valence Ytterbium Compound Yb<sub>4</sub>Ga<sub>24</sub>Pt<sub>9</sub>: Synthesis, Crystal Structure, and Physical PropertiesOlga Sichevych, Yurii Prots, Yuki Utsumi, et al.
Nature|July 21, 2017
Experimental signatures of the mixed axial-gravitational anomaly in the Weyl semimetal NbPJohannes Gooth, Anna C Niemann, Tobias Meng, et al.
Nature Communications|November 22, 2017
Extremely high magnetoresistance and conductivity in the type-II Weyl semimetals WP<sub>2</sub> and MoP<sub>2</sub>Nitesh Kumar, Yan Sun, Nan Xu, et al.
European Journal of Cancer (Oxford, England : 1990)|July 12, 2011
Melanoma antigen family A identified by the bimodality index defines a subset of triple negative breast cancers as candidates for immune response augmentationThomas Karn, Lajos Pusztai, Eugen Ruckhäberle, et al.
BMC Cancer|April 19, 2011
Prospective evaluation of prognostic factors uPA/PAI-1 in node-negative breast cancer: phase III NNBC3-Europe trial (AGO, GBG, EORTC-PBG) comparing 6×FEC versus 3×FEC/3×DocetaxelEva J Kantelhardt, Martina Vetter, Marcus Schmidt, et al.
Journal of Geriatric Oncology|October 23, 2017
Geriatric assessment and biomarkers in patients with metastatic breast cancer receiving first-line mono-chemotherapy: Results from the randomized phase III PELICAN trialFriedemann Honecker, Nadia Harbeck, Claudia Schnabel, et al.
Pageof 35

Showing results (241-250 of 344) with videos related to

Sort By:
Pageof 35
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|December 5, 2013
Synchronous ovarian and endometrial cancer--an international multicenter case-control studyFlorian Heitz, Frederic Amant, Christina Fotopoulou, et al.
European Journal of Cancer (Oxford, England : 1990)|October 5, 2023
Adjuvant capecitabine versus nihil in older patients with node-positive/high-risk node-negative early breast cancer receiving ibandronate - The ICE randomized clinical trialMarcus Schmidt, Ulrike Nitz, Toralf Reimer, et al.
Heliyon|August 22, 2024
Changes in modifiable risk factors in women at increased risk for breast and ovarian cancer during the COVID-19 pandemicKathrin Stewen, Annika Droste, Christian Ruckes, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|October 9, 2012
Mitotic figure counts are significantly overestimated in resection specimens of invasive breast carcinomasHans-Anton Lehr, Candice Rochat, Cornelia Schaper, et al.
Inorganic Chemistry|July 19, 2017
Intermediate-Valence Ytterbium Compound Yb<sub>4</sub>Ga<sub>24</sub>Pt<sub>9</sub>: Synthesis, Crystal Structure, and Physical PropertiesOlga Sichevych, Yurii Prots, Yuki Utsumi, et al.
Nature|July 21, 2017
Experimental signatures of the mixed axial-gravitational anomaly in the Weyl semimetal NbPJohannes Gooth, Anna C Niemann, Tobias Meng, et al.
Nature Communications|November 22, 2017
Extremely high magnetoresistance and conductivity in the type-II Weyl semimetals WP<sub>2</sub> and MoP<sub>2</sub>Nitesh Kumar, Yan Sun, Nan Xu, et al.
European Journal of Cancer (Oxford, England : 1990)|July 12, 2011
Melanoma antigen family A identified by the bimodality index defines a subset of triple negative breast cancers as candidates for immune response augmentationThomas Karn, Lajos Pusztai, Eugen Ruckhäberle, et al.
BMC Cancer|April 19, 2011
Prospective evaluation of prognostic factors uPA/PAI-1 in node-negative breast cancer: phase III NNBC3-Europe trial (AGO, GBG, EORTC-PBG) comparing 6×FEC versus 3×FEC/3×DocetaxelEva J Kantelhardt, Martina Vetter, Marcus Schmidt, et al.
Journal of Geriatric Oncology|October 23, 2017
Geriatric assessment and biomarkers in patients with metastatic breast cancer receiving first-line mono-chemotherapy: Results from the randomized phase III PELICAN trialFriedemann Honecker, Nadia Harbeck, Claudia Schnabel, et al.
Pageof 35